Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil for prevention of postoperative nausea and vomiting after laparoscopic bariatric surgery
IRCT20160903029656N2Phase 2Completed
- Sponsor
- Shahed University
- Start
- Jan 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Dexmedetomidine + propofol with Remifentanil + propofol (2 arms). Primary endpoint: Postoperative nausea and vomiting. Started Jan 2018; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20160903029656N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160903029656N2.